« on: May 06, 2021, 08:07:18 PM »
0
0
Big Pharma Co. pfιzєr Cashes in on CÖVÌD-19 Crisis
When the Wuhan virus, aka the novel cσɾσnαvιɾυs or CÖVÌD-19, started to roll around the globe in January 2020 and countries worldwide began shuttering businesses and schools, terrified people did as they were told and masked up and hunkered down in their homes. The mainstream media happily perpetuated a fear of the “dєαdlу virus” that would wipe out huge numbers of the populace. And pharmaceutical companies quickly saw a business opportunity that would turn out to be extremely profitable. Amid the global terror, caused by a “dangerous” invisible enemy, a miraculous cure was needed, and at warp speed.According to the latest data from Investopedia, pfιzєr, thanks to its CÖVÌD-19 ναccιnє, beat all forecasts and generated hundreds of millions in profits — $900 million, to be exact — in the first quarter of 2021. What’s interesting about the company’s success is that its ναccιnє is one of just two widely used and produced on a for-profit basis.Unlike its Western competitors Johnson & Johnson and AstraZeneca, the American-owned pfιzєr decided early to profit from its ναccιnє. That profit margin hasn’t been disclosed, but it was predicted to be in the high 20 percent range. The annual ναccιnє revenue is forecasted to beat $26 billion — a staggering sum that would make the shot the most lucrative medicine in pharmaceutical industry history measured by sales in a single year.pfιzєr CEO Albert Bourla said the company expects to see “durable demand” for its shot, similar to the market for influenza ναccιnєs. pfιzєr and BioNTech have significantly expanded their manufacturing capacity and claim they can produce at least three billion doses next year, while seeking to expand its market to reach adolescents and children as young as two. They also started testing the ναccιnє on six-month-old infants.pfιzєr sells its ναccιnє sales at different rates. The United States, for example, pays $19.50 for each dose, the European Union (EU) got a slightly better deal — € 15.5 ($18.0), while Israel has reportedly paid $47.pfιzєr has said repeatedly, that it was never part of the U.S. government’s Operation Warp Speed and therefore should be allowed to set its own prices.However, this statement from pfιzєr is deceptive. BioNTech, the company that actually developed the ναccιnє, of which pfιzєr basically slapped on its label, received a $455 million grant from the German government and around $6 billion in purchase commitments from the United States and the EU. Not only that, but the pfιzєr ναccιnє is based on mRNA technology patented by the National Institutes of Health, funded by U.S. tax dollars. On July 22, pfιzєr agreed to a $1.95 billion deal with the Tɾυmρ administration “for large-scale production and nationwide delivery of 100 million doses of a CÖVÌD-19 ναccιnє in the United States following the ναccιnє’s successful manufacture and approval.”Technically, that agreement has nothing to do with the rapid development of the ναccιnє, though it appears to undermine the claim that pfιzєr was operating entirely outside Operation Warp Speed.In a nutshell, pfιzєr capitalized on a partnership with a then-obscure German biotech company that received German government grants to develop its ναccιnє based on U.S. taxpayer-funded technology, and then received purchasing guarantees from wealthy governments that guaranteed billions in revenue. It managed to privatize all the profits while socializing all the risk.Shares in pfιzєr, BioNTech, and mσdernα were down on Thursday morning in premarket trading, after U.S. Trade Representative Katherine Tai said the U.S. supports the waiver of intellectual-property protections on CÖVÌD-19 ναccιnєs in order to quicken the pace of distribution and manufacturing of ναccιnєs around the world. President Bıdɛn confirmed shortly before the release of Tai’s statement that he was planning on backing the proposal.The news comes amid substantial concerns over the novel mRNA ναccιnєs’ safety. Doctors and physicians argue that these so-called ναccιnєs — or, more properly, unapproved experimental gene-therapy injections never before used in humans — may cause severe health implications that include death (The New American has covered it in detail here, here, and here), and unpredictable long-term gene damage and mutations that may potentially harm people’s immune and reproductive systems, leading to cancer and numerous other diseases.In this light, a global race of nations to get adults and children injected with something possibly much more dangerous than CÖVÌD-19 itself, which is extremely treatable, while paying enormous sums of money, looks like pure insanity.https://tinyurl.com/3335pmkv
Logged
"In His wisdom," says St. Gregory, "almighty God preferred rather to bring good out of evil than never allow evil to occur."
Topic: Big Pharma Co. pfιzєr Cashes in on CÖVÌD-19 Crisis (Read 109 times)